2185.HK

Shanghai Bio-heart Biological Technology Co., Ltd. 2185.HK

2185.HK
Shanghai Bio-heart Biological Technology Co., Ltd. 1244.HK
3D Medicines Inc. 6628.HK
Transcenta Holding Limited 2257.HK
Sirnaomics Ltd. 2126.HK
JW (Cayman) Therapeutics Co. Ltd 6622.HK
Zhaoke Ophthalmology Limited 3681.HK
SinoMab BioScience Limited 2496.HK
Wuhan YZY Biopharma Co Ltd 2137.HK
Brii Biosciences Limited 2511.HK
HighTide Therapeutics Inc

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 2185.HK 1244.HK 6628.HK 2257.HK 2126.HK 6622.HK 3681.HK 2496.HK 2137.HK 2511.HK
6M 221.16 % 64.96 % 155.00 % 266.56 % 121.02 % 77.01 % 17.56 % 50.85 % -11.50 % 117.06 %
YTD 396.15 % 80.53 % 410.00 % 223.50 % 173.23 % 142.52 % 41.28 % -10.71 % 80.61 % 229.46 %
1Y 337.29 % 135.38 % 200.00 % 261.86 % 110.30 % 120.00 % 12.41 % 15.47 % 70.19 % 229.46 %
3Y -84.79 % -80.54 % -21.94 % -80.91 % 22.61 % 45.97 % -14.44 % -56.45 % -65.63 % -70.19 %
5Y -61.49 % -80.54 % -76.89 % -85.51 % -84.23 % -78.49 % -51.11 % -56.45 % -92.29 % -70.19 %
10Y -61.49 % -80.54 % -76.89 % -85.51 % -84.23 % -78.49 % -74.33 % -56.45 % -92.29 % -70.19 %
From the beginning -61.49 % -80.54 % -76.89 % -85.51 % -84.23 % -78.49 % -74.33 % -56.45 % -92.29 % -70.19 %

Dividend